Literature DB >> 10980878

The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure.

W L Lombardi1, E M Gilbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10980878     DOI： 10.1007/s11886-000-0004-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   3.955


× No keyword cloud information.
  76 in total

1.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

Authors:  P Lechat; M Packer; S Chalon; M Cucherat; T Arab; J P Boissel
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

2.  Placebo-controlled study of lisinopril in congestive heart failure: a multicentre study.

Authors:  J P Chalmers; M J West; J Cyran; D De La Torre; M Englert; M Kramar; G R Lewis; M F Maranhao; D P Myburgh; P Schuster
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

3.  Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.

Authors:  B D Lowes; E A Gill; W T Abraham; J R Larrain; A D Robertson; M R Bristow; E M Gilbert
Journal:  Am J Cardiol       Date:  1999-04-15       Impact factor: 2.778

4.  Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.

Authors: 
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

5.  Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.

Authors:  M St John Sutton; M A Pfeffer; L Moye; T Plappert; J L Rouleau; G Lamas; J Rouleau; J O Parker; M O Arnold; B Sussex; E Braunwald
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

6.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

7.  Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth.

Authors:  P Anversa; C Beghi; Y Kikkawa; G Olivetti
Journal:  Circ Res       Date:  1986-01       Impact factor: 17.367

8.  Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

Authors:  M St John Sutton; M A Pfeffer; T Plappert; J L Rouleau; L A Moyé; G R Dagenais; G A Lamas; M Klein; B Sussex; S Goldman
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

9.  Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein.

Authors:  G J Bhat; T J Thekkumkara; W G Thomas; K M Conrad; K M Baker
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

10.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728
View more
  2 in total

1.  Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats.

Authors:  Jewell A Jessup; Sarah H Lindsey; Hao Wang; Mark C Chappell; Leanne Groban
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

2.  Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.

Authors:  Ailan Chen; Wanglin Li; Xinyu Chen; Yuechun Shen; Wenjun Dai; Qi Dong; Xinchun Li; Caiwen Ou; Minsheng Chen
Journal:  BMC Cardiovasc Disord       Date:  2016-11-17       Impact factor: 2.298
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.